UNSPSC 85471132: Map basal ganglia, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to map basal ganglia, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 00K83ZZ

UNSPSC 85471132 Map basal ganglia, percutaneous approach is a Commodity code with little recent state and local procurement activity aligned to its nominal medical-procedure scope. The five recent opportunities tagged to this code instead reflect broad healthcare service procurement across correctional facilities, county employee benefits administration, telemedicine platforms, behavioral health support, and fire department medical direction — none of which involve basal ganglia mapping or percutaneous neurological procedures. The mismatch between the code's technical medical definition and the actual work being solicited suggests either systematic miscoding in state and local procurement systems or that this code is not actively used for its intended purpose in state and local health procurement.

The recent activity spans multiple issuing bodies and geographic regions: Muscogee County (Georgia) soliciting inmate medical and pharmacy services via RFP (due May 15, 2026); Collier County (Florida) procuring pharmacy benefit management services via RFP (posted April 9, 2026); Monroe County (Florida) seeking virtual primary and urgent care services via RFP (due April 16, 2026); San Mateo County (California) issuing an RFP for peer support services for peer workers totaling $580,000 in funding (due July 2, 2025); and the Santa Monica Fire Department (California) recruiting a medical director via RFP (due October 16, 2025). None of these solicitations involves diagnostic imaging, neurological mapping, or interventional procedures. Firms pursuing work under this code should verify coding accuracy with state and local procurement offices before investing in pursuit resources, as the current opportunity set does not reflect the clinical scope the code nominally describes.